Endocrine effects of combination antioestrogen and LH-RH agonist therapy in premenopausal patients with advanced breast cancer.

[1]  A. Manni.  Tamoxifen therapy of metastatic breast cancer. , 1987, The Journal of laboratory and clinical medicine.

[2]  M. Williams,et al.  Preliminary endocrinological evaluation of a sustained-release formulation of the LH-releasing hormone agonist D-Ser(But)6Azgly10LHRH in premenopausal women with advanced breast cancer. , 1986, The Journal of endocrinology.

[3]  M. Williams,et al.  The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer. , 1986, British Journal of Cancer.

[4]  M. Williams,et al.  Endocrinological and clinical aspects of LHRH action (ICI 118630) in hormone dependent breast cancer. , 1985, Journal of steroid biochemistry.

[5]  F. Hutchinson,et al.  Biodegradable polymers for the sustained release of peptides. , 1985, Biochemical Society transactions.

[6]  R. Nicholson,et al.  POTENTIAL ANTIOESTROGENIC AND ANTITUMOUR MECHANISMS OF TAMOXIFEN ACTION IN BREAST CANCER , 1982 .

[7]  B. Hoogstraten,et al.  Tamoxifen and oophorectomy in the treatment of recurrent breast cancer: a Southwest Oncology Group Study. , 1982, Cancer research.

[8]  A. Harris,et al.  Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial. , 1981, British medical journal.

[9]  L. Beex,et al.  Tamoxifen versus ethinyl estradiol in the treatment of postmenopausal women with advanced breast cancer. , 1981, Cancer treatment reports.

[10]  A. Manni,et al.  Antihormone treatment of stage IV breast cancer , 1979, Cancer.

[11]  Tagnon Hj.  Antiestrogens in treatment of breast cancer. , 1977 .

[12]  D. London,et al.  Recurrent breast cancer treated with the antioestrogen tamoxifen: correlation between hormonal changes and clinical course. , 1977, British medical journal.

[13]  K. Griffiths,et al.  Plasma hormones in patients with advanced breast cancer treated with tamoxifen. , 1976, European journal of cancer.

[14]  Ward Hw.  Antioestrogens in treatment of breast cancer. , 1974 .

[15]  R. Blamey,et al.  Therapeutic significance and the mechanism of action of the LH-RH agonist ICI 118630 in breast and prostate cancer. , 1984, Journal of steroid biochemistry.

[16]  B. Furr,et al.  The pharmacology and clinical uses of tamoxifen. , 1984, Pharmacology & therapeutics.

[17]  J. Ingle,et al.  Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer. , 1981, The New England journal of medicine.

[18]  A. Forrest,et al.  The tamoxifen trial - a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer. , 1980, European journal of cancer.

[19]  K. Pritchard,et al.  Tamoxifen therapy in premenopausal patients with metastatic breast cancer. , 1980, Cancer treatment reports.